n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, August 2nd, 2016

The QualityStocks
Daily Stock List

graphic
graphic

Pure Energy Minerals Limited (HMGLF)

Uncommon Wisdom, Stock Beast, and InvestorIntel reported earlier on Pure Energy Minerals Limited (HMGLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pure Energy Minerals Limited is an emerging leader in the development of pioneering, resource efficient mineral exploration and project development. The OTCQB-listed Company is a lithium-brine resource developer. Its emphasis is on its flagship lithium brine project (the Clayton Valley South (CVS) Lithium Brine Project), in Clayton Valley, Nevada. Pure Energy Minerals is based in Vancouver, British Columbia. Esmeralda Minerals LLC is a wholly-owned subsidiary of the Company.

Pure Energy Minerals’ flagship lithium brine project is positioned contiguous and to the southeast of North America’s only producing lithium mine, the Silver Peak mine owned by Albemarle. The CVS project has substantial existing infrastructure. It is positioned to meet the U.S. domestic market and has good access to Asian markets. The CVS project is acreage in three main claim groups in the southern half of Clayton Valley, Esmeralda County, Nevada. The project has an inferred mineral resource of 816,000 metric tonnes of Lithium Carbonate Equivalent (LCE), reported in accordance with NI 43-101.

The deposit is a salty groundwater (brine) with high levels of lithium contained in two aquifers (Main Ash Aquifer and Lower Aquifer System), which underlie the Company’s claim area. Pure Energy Minerals will employ innovative process technologies to produce low-cost, high-quality lithium products.

The Company is also collaborating with global multinational technology partners (POSCO, Tenova Bateman) and world-class research institutes (SRI, UBC) towards demonstrating and deploying, low-cost and earth-friendly processing technologies. This is to produce advanced lithium battery materials to meet the expected demand forecasts. Metallurgical and process studies are taking place to better understand the feasibility and economics of utilizing modern environmentally-responsible processing technology to convert the CVS brines into high purity lithium products for new energy storage uses.

Pure Energy Minerals reported in November 2015, that, via Esmeralda Minerals, it secured an additional 1320 acres (534 hectares) of lithium placer mining claims (CA claims) in Clayton Valley, Nevada. The Company’s total project size is now roughly 9,324 acres (3,773 hectares).

Recently, Pure Energy Minerals announced that exploration borehole CV-3 was successfully drilled to a total depth of 2,000 feet below ground level (610 metres) at its Clayton Valley South (CVS) Lithium Brine Project. The original target depth for this well was 1,600 feet (490 metres). However, favorable drilling conditions and positive return of cuttings and formation fluids supported extending the depth of investigation down to the final depth. The well has been completed to a diameter of 12.5 inches (32 centimetres). The new well will serve the dual purpose of deep exploration and monitoring for pumping tests.

Pure Energy Minerals Limited (HMGLF), closed Tuesday's trading session at $0.689, down 0.14%, on 574,135 volume with 263 trades. The average volume for the last 60 days is 427,425 and the stock's 52-week low/high is $0.2656/$0.911.

Enumeral Biomedical Holdings, Inc. (ENUM)

Today we are reporting on Enumeral Biomedical Holdings, Inc. (ENUM), here at the QualityStocks Daily Newsletter.

Enumeral Biomedical Holdings, Inc. is discovering and developing novel antibody immunotherapies, which help the immune system in attacking diseased cells. The Company is building a pipeline of immunomodulators for the treatment of cancer and inflammatory diseases and leveraging the breadth of its technology by way of strategic collaborations. Its unique platform enables it to identify and characterize promising new drugs relevant to cancer, infectious, and inflammatory diseases. Enumeral Biomedical Holdings is based in Cambridge, Massachusetts.

The Company is enabling and hastening the discovery and development of novel antibody immunotherapies, or immunomodulators that are validated with its human-driven immune profiling platform. Enumeral’s immunoprofiling platform harnesses The Power of Human™. Enumeral believes that its cellular functional profiling techniques provide for a deeper understanding of the diversity of human responses and provide a more rational foundation to guide immunotherapy design and development. The Company believes it has a unique ability to broadly interrogate the human immune microenvironment for candidate selection and validation.

Enumeral believes its innovative capabilities enable it to measure drug effects in a patient-specific manner, providing the basis for developing best-in-class product candidates, founded on a fundamental understanding of how immunotherapies work in each patient. The core technology underlying its platform was developed at, and licensed from, the Massachusetts Institute of Technology (MIT), Harvard University, and Whitehead Institute for Biomedical Research and Massachusetts General Hospital.

Enumeral Biomedical is building a pipeline focused on next-generation checkpoint modulators, with initial targets including PD-1, TIM3, LAG-3, TIGIT, and VISTA. In developing these agents, the Company’s researchers apply a proprietary immune profiling technology platform that measures functioning of the human immune system at the level of individual cells. This provides important insights for candidate selection and validation. The Company aims to move its lead PD-1 antagonist into clinical testing during the second half of 2016, with additional programs moving toward IND-enabling studies.

Recently, Enumeral Biomedical announced that, as contemplated in the April 18, 2016 License and Transfer Agreement, it received a $750,000 license maintenance fee from and entered into a Definitive License and Transfer Agreement with Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH to continue Pieris’ license to Enumeral’s 388D4 anti-PD-1 antibody. Pieris Pharmaceuticals is a clinical-stage biotechnology company. Pieris discovers and develops Anticalin-based drugs to target validated disease pathways in an innovative and transformative way.

Enumeral Biomedical Holdings, Inc. (ENUM), closed Tuesday's trading session at $0.17, even for the day, on 3,333 volume with 1 trade. The average volume for the last 60 days is 21,322 and the stock's 52-week low/high is $0.128/$0.70.

Gilla, Inc. (GLLA)

SmallCapVoice, SmallCapFinancialWire, and Greenbackers reported on Gilla, Inc. (GLLA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Gilla, Inc. manufactures, markets, and distributes E-liquid, the liquid used in vaporizers, and E-cigarettes, and other vaping hardware and accessories. E-cigarettes are increasingly being considered as an alternative to conventional tobacco cigarettes. They provide authentic smoking pleasure and do not burn tobacco. Nonetheless, they are not smoking cessation devices. Gilla is based in Daytona Beach, Florida. The Company lists on the OTC Markets Group’s OTCQB.

Gilla’s product portfolio includes Coil Glaze, Craft Vapes, Craft Clouds, Miss Pennysworth's Elixirs, The Mad Alchemist, Vape Warriors, Surf Sauce, Siren, and The Drip Factory, Crown and Replicant. The Company’s aim is to become a global leader in the manufacturing and distribution of E-liquid brands and proprietary recipes for the vapor industry.

E-cigarettes and vaporizers are replacements for traditional cigarettes. E-cigarettes produce no offensive smells or second hand smoke. E-cigarettes enable smokers to reproduce the smoking experience. E-liquid is heated by the atomizer to deliver the sensation and taste of smoking.

Gilla has a two-branch business model. One is Custom E-liquid Manufacturing. This includes private label solutions, E-Liquid flavoring and fulfilment services. The other is Marketing & Online Services. This includes branding, marketing, sales support, and e-commerce solutions.

In January 2016, Gilla announced that it formed Gilla Europe Kft. and hired a top E-cig sales and distribution management team. The move brings on board a foremost E-cig distribution platform accessing more than 25 European nations and encompassing greater than 30 languages.

Moreover, Gilla has expanded into another European stronghold for e-cig vaping, the United Kingdom. Gilla has agreed with a major vape store chain with in excess of 50 physical locations, and a sizeable online presence, to carry its award winning Coil Glaze product line. In addition, Gilla has decided to employ a local manufacturer, with its own distribution network of more than 600 vape shops, to handle the bottling and boxing of the product.

Furthermore, Gilla earlier signed an exclusive distribution agreement for China with an industry-leading manufacturer of E-cigarettes and other vaping hardware. The agreement includes exclusivity for the Company's complete line of E-liquid brands with the distributor. It includes a minimum purchase amount of $5.5 million worth of product over the next three years to maintain its exclusivity within China.

Gilla, Inc. (GLLA), closed Tuesday's trading session at $0.152, down 5.00%, on 4,445 volume with 2 trades. The average volume for the last 60 days is 5,141 and the stock's 52-week low/high is $0.055/$0.20.

Ascent Solar Technologies, Inc. (ASTI)

Profitable Trader Authority, Promotion Stock Secrets, StreetInsider, PennyPro, SuperStockTips, InvestorSoup, Penny Stock Craze, Stock Preacher, Beacon Equity Research, and Penny Stocks Finder reported recently on Ascent Solar Technologies, Inc. (ASTI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ascent Solar Technologies, Inc. is a developer and manufacturer of state-of-the-art, flexible, thin-film photovoltaic modules integrated into its EnerPlex™ series of consumer products. The Company is a developer of award-winning thin-film photovoltaic modules with substrate materials that are more flexible, versatile, and stronger than traditional solar panels.

EnerPlex is Ascent Solar Technologies’ brand of consumer products. EnerPlex is a division of Ascent Solar. Ascent Solar’s Research and Development (R&D) and its 30 MW nameplate production facility is in Thornton, Colorado. The EnerPlex Division represents Ascent Solar's consumer-facing business and products.

Ascent Solar’s technology is thin-film CIGS on flexible, plastic substrate. The Company’s manufacturing is roll-to-roll manufacturing, monolithic integration & intelligent process control. Its business divisions are: Solar Solutions - Aerospace, UAVs, Military, Specialty Applications, Consumer Market & Transportation; and
Power Storage Solutions - Mobility, Outdoor & Emergency Portable Power.

Ascent Solar Technologies’ flexible, lightweight CIGS modules enable seamless integration of solar power into an unlimited number of applications without the restrictions of normal glass panels. Its modules can be directly integrated into consumer products and off-grid applications. In addition, they can be directly integrated into aerospace and building integrated applications.

The Company’s CIGS panels weigh a small fraction of conventional c-Si panels. Pertaining to CIGS chemistry, they have the highest thin-film conversion efficiency. Furthermore, they have the best Power-to-Weight Ratio (50 - 250 watt/kg).

Ascent Solar Technologies has attained a significant breakthrough in power-to-weight ratio for its superlight solar module, delivering greater than 1700 watts of power per kilogram, operating at AM0, technically called the space environment. With this performance, its superlight module would weigh 66 percent less than a comparable PV system using the highest-quality crystalline silicon and with much less design complexity. Ascent Solar Technologies said that elimination of two-thirds of the weight is a vital improvement for satellites, space vehicles, and space stations.

Today, Ascent Solar Technologies announced that it will debut the Kickr 7FL and Kickr 10FL, the world's lightest consumer solar chargers, at Outdoor Retailer this month in addition to the new EnerPlex Explor and EnerPlex Packr BC. EnerPlex continues to establish itself as the technology leader in Mobility Power, with the introduction of Featherlight solar family (the Kickr 7FL and 10FL) and the EnerPlex Explor 67, the brand's first battery designed precisely for the outdoors, carrying an IP67 rating and the EnerPlex Packr BC, a first of its type solar charger, designed from the ground up for backpackers.

Ascent Solar Technologies, Inc. (ASTI), closed Tuesday's trading session at $0.051, up 58.88%, on 9,009,416 volume with 534 trades. The average volume for the last 60 days is 1,134,317 and the stock's 52-week low/high is $0.025/$8.20.

Q2Power Technologies, Inc. (QPWR)

We are highlighting Q2Power Technologies, Inc. (QPWR) today, here at the QualityStocks Daily Newsletter.

Q2Power Technologies, Inc. is working to become a top provider of waste management services for small-scale waste water treatment plants and other producers of methane and organic waste. The design of the Company’s proprietary engine systems is for small-scale applications. These systems convert thermal energy (heat) produced in the destruction of biogas into mechanical power. Q2Power sells this distributed electric power (and heat) back to its customers by way of Power Purchase Agreements (PPA’s). Q2Power Technologies has its corporate headquarters in Lancaster, Ohio and the Company’s shares trade on the OTC Markets’ OTCQB.

Q2Power’s present combined heat and power (CHP) technology can undergo deployment with minimal time and expense at thousands of small-scale facilities, which must dispose of waste such as methane, biogas and other used fuels at increasingly greater costs and regulatory burdens. Through an association with ERTH Products, Q2Power can also convert bio-solid waste from water treatment plants into beneficial reuse products, including Class A compost and engineered soils.

Q2Power Technologies earlier entered into a Collaboration Agreement with Phoenix Power Group. The Agreement provides cross licensing rights between the two parties for Q2Power's proprietary waste-to-power engine and controls, and Phoenix Power Group 's proprietary waste liquid fuel combustion system. Phoenix Power Group is a developer of combined heat and power systems (CHP Systems) that run on used motor oil and other waste fuels.

This past June, Q2Power Technologies provided more information on its expansion plans into the compost and engineered soils industry, an extension of its work developing environmentally sustainable cost-cutting solutions for waste water treatment facilities.

Mr. Kevin Bolin, Q2Power Technologies’ Chairman, stated, "We see a major opportunity in the composting and engineered soils markets to build a strong, cash flowing company, while doing good for the environment. Q2Power intends to partner with and possibly acquire established businesses in this sector over the following year. Expanding this business is a matter of manufacturing consistently high-quality products, creating robust marketing and educational programs, and possibly consolidating companies in strategic locations throughout the United States. We believe we can be successful with this plan."

Q2Power Technologies, Inc. (QPWR), closed Tuesday's trading session at $0.16, up 5.27%, on 220,000 volume with 5 trades. The average volume for the last 60 days is 90,027 and the stock's 52-week low/high is $0.10/$0.75.

graphic

The QualityStocks
Company Corner

graphic
graphic

Cherubim Interests, Inc. (CHIT)

The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.0349, up 34.23%, on 6,384 volume with 3 trades. The stock’s average daily volume over the past 60 days is 11,829, and its 52-week low/high is $0.0201/$700.00.

Cherubim Interests, Inc. is pleased to announce that it has executed a distribution agreement with XWALLS, which provides liberating spaces that foster connections through the evolutionary hybridization of walls and windows. By rescuing workers from ineffectual drywall offices and partitioned cubicles, XWALLS is a transformative way to bring people, places and ideas together. The result is environments and spaces that spur creativity, invite collaboration, and foster innovation in an ever more technologically interconnected world.

Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.

The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.

Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.

Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer

Cherubim Interests, Inc. Company Blog

Cherubim Interests, Inc. News:

Cherubim Interests, Inc. Signs Distribution Agreement With XWALLS Inc.

Cherubim Interests, Inc. Signs LOI to Construct Single-Family Residential Rental Properties

Cherubim Interests, Inc. Announces Letter to Shareholders

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0128, off by 1.54%, on 2,254,766 volume with 58 trades. The stock’s average daily volume over the past 60 days is 821,353, and its 52-week low/high is $0.0041/$0.018.

Singlepoint, Inc. announces today that its Board has approved initiatives to build a mobile app that caters to bringing like-minded Pokémon Go players together by offering rewards backed communication opportunities for players. Apple recently confirmed that Pokémon Go was downloaded more times during its first week than any other app in the App Store's history. Pokémon Go had 21 million active users in the United States alone as of 18 July -- less than two weeks after going live. The game, which has been rolled out in 35 countries, is also available on Android devices. Needham and Co brokerage analysts state that Pokémon Go's ratio of paid users to total users was 10 times that of Candy Crush, the hit game from King Digital that generated more than $1bn of revenue in both 2013 and 2014.

Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.

SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.

SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.

As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint, Inc. to Capitalize on the Multi-Million Dollar 'Pokemon Go' Phenomenon With Custom Mobile Application

SinglePoint, Inc. Identifies Acquisition and Funding Targets; Updates on MaloneBailey Audit Toward Uplist

A New Audio Interview with Greg Lambrecht, CEO of SinglePoint Inc., is Now at SmallCapVoice.com

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $1.98, up 3.94%, on 1,526 volume with 10 trades. The stock’s average daily volume over the past 60 days is 4,967, and its 52-week low/high is $1.25/$6.95.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC

International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease

Moxian, Inc. (MOXCD)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXCD). Today, Moxian, Inc. closed trading at $6.5575, even with yesterday's close, on 80 volume with 1 trade. The stock’s average daily volume over the past 60 days is 54, and its 52-week low/high is $6.308/$13.00.

Moxian, Inc. (MOXCD) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data

Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate

Moxian, Inc. Covered by Crystal Equity Research

OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.89, up 0.52%, on 900 volume with 2 trades. The stock’s average daily volume over the past 60 days is 4,256, and its 52-week low/high is $0.631/$1.06.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

OurPet's Company (OPCO) Has a New Natural Solution to Your Cat Litter Woes

OurPet's Company Now Licensing Polymer Bonded Pet Bowl Patent

OurPet's Company Sponsors 65th Annual BetterInvesting National Convention

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

OTCtipReporter
(SHIP)

2.

QualityStocks
(ASTI)

3.

Profitable Trader Authority
(GETH)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251